Clinical Trials Directory

Trials / Sponsors / Myovant Sciences GmbH

Myovant Sciences GmbH

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in H
Healthy
Phase 12021-01-06
CompletedStudy of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated
Uterine Leiomyoma, Uterine Fibroids
Phase 32018-10-16
CompletedBone Mineral Density in Women With Uterine Fibroids or Endometriosis
Uterine Fibroid, Endometriosis
—2018-08-03
CompletedSPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain
Endometriosis
Phase 32018-05-22
CompletedSPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Endometriosis Related Pain
Phase 32017-12-07
CompletedSPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Endometriosis Related Pain
Phase 32017-11-01
CompletedLIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Ass
Heavy Menstrual Bleeding, Uterine Fibroid
Phase 32017-10-19
CompletedLIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine
Heavy Menstrual Bleeding, Uterine Fibroid
Phase 32017-06-14
CompletedLIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine
Heavy Menstrual Bleeding, Uterine Fibroid
Phase 32017-04-26
CompletedA Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
Prostate Cancer
Phase 32017-04-18
CompletedStudy of Relugolix Alone and Relugolix Combined With Hormonal Add-Back Therapy in Healthy Premenopausal Female
Healthy
Phase 12016-06-16